2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$360.50-$2.89 (-0.80%)
Price as of Jul 13, 2026 7:13 PM EDT- $196.1BMarket Cap
- 26.77%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$360.50-$2.89 (-0.80%)
AMGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $363.39 | ||
Change | -$0.23 (-0.06%) | ||
Open | $363.08 | ||
High | $364.89 | ||
Low | $361.14 | ||
Previous Close | $363.62 | ||
Volume | 1,632,746 | ||
30-Day Average Volume | 2,981,887 | ||
1-Week Change | -2.88% | ||
1-Month Change | 7.60% | ||
1-Year Change | 26.77% | ||
3-Year Change | 77.31% | ||
5-Year Change | 73.47% | ||
Fundamentals | |||
Shares Outstanding | 539.7M | ||
Total Assets | $92.5B | ||
Market Cap | $196.1B | ||
Enterprise Value | $241.4B | ||
Period: QTR TTM FY | |||
Revenue | $8.2B | ||
Net Income | $1.8B | ||
Free Cash Flow | $1.5B | ||
EBIT | $2.7B | ||
EBITDA | $3.9B | ||
Net Working Capital | $6.5B | ||
EPS | $3.34 | ||
Enterprise Value/EBITDA | 63 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 21 | ||
P/E | 109 | ||
PEG | 3 | ||
Price/Free Cash Flow | 133 | ||
Price/Operating Cash Flow | 90 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.77% | ||
Trailing Annual Dividend Yield | 2.70% | ||
Ex-Dividend Date | 05/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield